A detailed history of Conway Capital Management, Inc. transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Conway Capital Management, Inc. holds 141,500 shares of CLPT stock, worth $2.29 Million. This represents 0.77% of its overall portfolio holdings.

Number of Shares
141,500
Holding current value
$2.29 Million
% of portfolio
0.77%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$5.3 - $13.18 $749,950 - $1.86 Million
141,500 New
141,500 $1.59 Billion
Q2 2023

Dec 02, 2024

SELL
$6.54 - $10.58 $339,262 - $548,837
-51,875 Closed
0 $0
Q1 2023

Dec 02, 2024

SELL
$7.33 - $10.63 $92,724 - $134,469
-12,650 Reduced 19.6%
51,875 $438 Million
Q4 2022

Dec 02, 2024

SELL
$7.7 - $11.21 $378,840 - $551,532
-49,200 Reduced 43.26%
64,525 $547 Million
Q3 2022

Dec 02, 2024

BUY
$9.82 - $16.49 $260,809 - $437,957
26,559 Added 30.47%
113,725 $1.18 Billion
Q2 2022

Dec 02, 2024

BUY
$7.09 - $13.65 $318,518 - $613,226
44,925 Added 106.35%
87,166 $1.14 Billion
Q1 2022

Dec 02, 2024

BUY
$7.8 - $11.6 $125,509 - $186,655
16,091 Added 61.53%
42,241 $440 Million
Q4 2021

Dec 02, 2024

SELL
$11.08 - $18.86 $837,648 - $1.43 Million
-75,600 Reduced 74.3%
26,150 $293 Million
Q3 2021

Dec 02, 2024

SELL
$16.58 - $22.25 $241,238 - $323,737
-14,550 Reduced 12.51%
101,750 $1.81 Billion
Q2 2021

Dec 02, 2024

BUY
$17.23 - $22.77 $535,422 - $707,577
31,075 Added 36.46%
116,300 $2.22 Billion
Q1 2021

Dec 02, 2024

BUY
$15.19 - $29.0 $933,941 - $1.78 Million
61,484 Added 258.98%
85,225 $1.8 Billion
Q4 2020

Dec 02, 2024

SELL
$5.11 - $15.89 $601,748 - $1.87 Million
-117,759 Reduced 83.22%
23,741 $377 Million

Others Institutions Holding CLPT

About ClearPoint Neuro, Inc.


  • Ticker CLPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,488,300
  • Market Cap $396M
  • Description
  • ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...
More about CLPT
Track This Portfolio

Track Conway Capital Management, Inc. Portfolio

Follow Conway Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Conway Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Conway Capital Management, Inc. with notifications on news.